Cardinal Health 200 recalled Salem Sump silicone dual lumen stomach tubes on September 18, 2025. The recall affects all lots due to complaints of Anti-Reflux Valve breakage during use. Patients and healthcare providers should stop using the devices immediately.
Firm has received complaints regarding Anti-Reflux Valve (ARV) breakage due to excessive force during use. Firm is providing additional guidance for use. Expansion of RES 95214.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Cardinal Health 200, LLC or your healthcare provider for instructions. Notification method: Letter
The recall includes various models of Salem Sump silicone dual lumen stomach tubes with product codes 8888265108, 8888265116, 8888265124, 8888265132, 8888265140, 8888266213, 8888266221, 8888266247, 8888266262, and 8888266288. These products were distributed worldwide, including across all U.S. states and several countries.
The company received complaints about the Anti-Reflux Valve breaking due to excessive force during use. This defect poses a high risk of injury to patients.
There are no specific numbers reported for injuries or incidents. The recall is based on multiple complaints regarding the valve breakage.
Patients and healthcare providers should stop using the affected tubes immediately. Contact Cardinal Health 200, LLC or your healthcare provider for further instructions. Follow the recall instructions provided in the notification letter.
For more information, call Cardinal Health at 1-800-200-2137 or visit their website at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-0208-2026.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.